ABC Dophilus is a dietary supplement sold by Solgar, Inc., and marketed specifically for infants and children as a “blend of beneficial friendly bacteria.”
However, testing by the Centers for Disease Control (CDC) discovered that the product contained Rhizopus oryzae, which can cause a rare but life-threatening infection called Mucormycosis.
One death has been linked to the product. According to the FDA:
“ABC Dophilus was used as part of the in-hospital course of treatment for a very preterm infant (under 32 week gestation) who suffered from multiple complications, including intestinal mucormycosis, and died on October 11, 2014.”
Solgar Inc. is asking customers not to use the product and return it for a full refund. They have suspended production and sales while investigating the source of the problem.
Risk-factors for infection include uncontrolled diabetes, cancer, organ transplant, neutropenia (low white blood cells), and skin trauma (cuts, scrapes, punctures, or burns). Susceptible patients who have used this product are asked to contact their doctor as soon as possible.
The recalled product have an expiration date of July 31, 2015. They belong to lot numbers 074024-01R1, 074024-01 and 074024-02 and are labeled with UPC Code: 0 33984 00010 0 with the following lot numbers: 074024-01R1, 074024-01 and 074024-02.
Do I have an ABC Dophilus Lawsuit?
The Schmidt Firm, PLLC is currently accepting ABC Dophilus induced injury cases in all 50 states. If your child or somebody you know has been diagnosed with an infection, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Dietary Supplement Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.